A Study Using The Bright Center Platform For Follow-up Management Of Patients With Diabetic Retinopathy

ObjectiveThe purpose of this paper was to Compare the differences between the follow-up management mode of Guangming Center platform and the traditional follow-up mode in the chronic disease management of diabetic retinopathy(Diabetic retinopathy,DR)patients,and analyze the superiority of the Guangming Center follow-up management mode in the chronic disease management of diabetic retinopathy.Use the Guangming Center follow-up mode to manage and guide patients to seek timely treatment,and provide a convenient and feasible way for DR chronic disease management.MethodsThis paper adopts a prospective observational study method.Collect patients with diabetic retinopathy who were treated at the Rocket Force Characteristic Medical Center Ophthalmology Department from January 2021 to August 2022.According to the inclusion exclusion criteria,they were randomly divided into the Bright Center follow-up mode group and the traditional follow-up mode group.collect general information of the subjects,eye examination,auxiliary examination results,past ocular history and treatment history,and score the patients’ fundus images according to the diabetic retinopathy severity score(Diabetic retinopathy severity score,DRSS)table.Analyze the eye conditions of DR patients using the Guangming Center platform follow-up management mode and the traditional follow-up mode.The follow-up system of Guangming Center helps patients better understand their condition through intervention treatment and tracking changes,and records patients’ information by establishing a database of fundus images of diabetic retinopathy.In addition,the system also reminds patients of precautions and follow-up times,while the traditional follow-up mode is routine outpatient follow-up,where patients visit the outpatient department,and the doctor informs them of the next follow-up time,and patients actively follow-up.The differences in follow-up compliance(First-line treatment rate,Regular follow-up rate),best-corrected visual acuity(BCVA),and DRSS score changes in DR patients between the two modes were compared.ResultsThe result of this paper is the standardized follow-up rate and first-line treatment implementation rate of the Guangming Center group were higher than those in the traditional follow-up group [(69.60±32.30)% vs.(52.30±28.90)%,67.74% vs.37.08%],and the BCVA(LogMAR)difference between revisit 1 and revisit 2 was higher than that in the traditional follow-up group [(-0.10±0.27)vs.(0.01±0.26),(-0.15±0.33)vs.(-0.09±0.36)],and the final DRSS was lower than that in the traditional follow-up group [(43.48±13.81)vs.(47.03±17.29)points]and DRSS fallback grade were higher than those in the traditional follow-up group [(-1.51±2.25)vs.(-0.56±2.55)],and the differences were statistically significant(P<0.05).There was no significant difference in BCVA(LogMAR)between the two groups(P>0.05).ConclusionsBy comparing the follow-up management model of the Bright Center platform with the traditional follow-up mode in the management of chronic diseases in patients with diabetic retinopathy,it is found that the follow-up mode of Guangming Center can improve the follow-up and treatment compliance of DR patients,help improve the visual acuity of DR patients and control the progress of DR with better effect,which is superior to the traditional model and is worth promoting.